Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Brazilian Reality of Hepatocellular Carcinoma - BRA-HEP: Multicenter Retrospective Study (Real World Evidence - RWE)

NCT06230328 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06230328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06230328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Brazilian Reality of Hepatocellular Carcinoma - BRA-HEP: Multicenter Retrospective Study (Real World Evidence - RWE)
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
April 15, 2024
Completion date
November 14, 2024
Enrollment
300 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma, hepatocellular carcinoma by bclc stage, hepatocellular carcinoma stage i, hepatocellular carcinoma stage ii, hepatocellular carcinoma stage iii